• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国泰晤士河北部和南部国民保健服务地区持续性非卧床腹膜透析腹膜炎管理与结局调查:对国际腹膜透析学会指南的支持。国际腹膜透析学会

A survey of CAPD peritonitis management and outcomes in North and South Thames NHS regions (U.K.): support for the ISPD guidelines. International Society for Peritoneal Dialysis.

作者信息

Kent J R, Almond M K

机构信息

Department of Medicine, Southend Hospital, Essex, United Kingdom.

出版信息

Perit Dial Int. 2000 May-Jun;20(3):301-5.

PMID:10898047
Abstract

OBJECTIVE

This survey examined the current management of continuous ambulatory peritoneal dialysis (CAPD) peritonitis and the effectiveness of the various antibiotic protocols in use.

DESIGN

The information required was elicited via a postal questionnaire.

SETTING

The questionnaire was posted to each renal dialysis unit offering CAPD throughout the North and South Thames National Health Service regions.

PATIENTS

All patients using CAPD at each responding unit were eligible for inclusion.

MAIN OUTCOME MEASURES

Each unit provided details of their CAPD peritonitis episodes for 1997. Each unit's empirical treatment regimen for CAPD peritonitis was sought in addition to response rates. Also requested were numbers for peritonitis episodes, recurrences, and negative cultures, plus the peritonitis rate per patient-month.

RESULTS

Thirteen units returned the questionnaire (87% of the survey population). Nine of the 13 units were using vancomycin regimens, with the remainder using cephalosporin regimens. The results were compared to the audit standards of the British Renal Association. Seventy percent of units reached the 80% mark for response rate; similar results were achieved with both the vancomycin and cephalosporin regimens. Ninety-two percent achieved the suggested peritonitis rate of 1 episode every 18 patient-months; 30% achieved the culture-negative rate of 10%. The average recurrence rate was 19%.

CONCLUSION

The units contacted achieved most of the standards suggested by the British Renal Association; however, wide variations did exist. Recent guidelines have suggested avoiding vancomycin-based regimens in order to reduce the incidence of vancomycin resistance. The suggested regimen of a cephalosporin with an aminoglycoside seems to represent a suitable alternative.

摘要

目的

本调查研究了持续性非卧床腹膜透析(CAPD)腹膜炎的当前管理方法以及各种正在使用的抗生素方案的有效性。

设计

所需信息通过邮寄问卷的方式获取。

设置

问卷被寄给了泰晤士河南北两岸国民医疗服务体系区域内提供CAPD的每个肾脏透析单位。

患者

每个回复单位中所有使用CAPD的患者均符合纳入条件。

主要观察指标

每个单位提供了其1997年CAPD腹膜炎发作的详细情况。除了有效率外,还询问了每个单位针对CAPD腹膜炎的经验性治疗方案。还要求提供腹膜炎发作次数、复发次数、培养阴性次数,以及每患者月的腹膜炎发生率。

结果

13个单位返回了问卷(占调查总体的87%)。13个单位中有9个使用万古霉素方案,其余单位使用头孢菌素方案。结果与英国肾脏协会的审核标准进行了比较。70%的单位达到了80%的有效率;万古霉素方案和头孢菌素方案都取得了类似的结果。92%的单位达到了每18患者月1次发作的建议腹膜炎发生率;30%的单位达到了10%的培养阴性率。平均复发率为19%。

结论

被联系的单位达到了英国肾脏协会建议的大多数标准;然而,确实存在很大差异。最近的指南建议避免使用基于万古霉素的方案,以降低万古霉素耐药性的发生率。建议的头孢菌素与氨基糖苷类药物联合方案似乎是一个合适的替代方案。

相似文献

1
A survey of CAPD peritonitis management and outcomes in North and South Thames NHS regions (U.K.): support for the ISPD guidelines. International Society for Peritoneal Dialysis.英国泰晤士河北部和南部国民保健服务地区持续性非卧床腹膜透析腹膜炎管理与结局调查:对国际腹膜透析学会指南的支持。国际腹膜透析学会
Perit Dial Int. 2000 May-Jun;20(3):301-5.
2
Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.头孢唑林联合奈替米星与头孢唑林联合头孢他啶治疗持续性非卧床腹膜透析相关性腹膜炎:对残余肾功能的影响
Kidney Int. 2005 Nov;68(5):2375-80. doi: 10.1111/j.1523-1755.2005.00700.x.
3
Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.持续非卧床腹膜透析患者腹膜炎经验性治疗中腹腔注射头孢唑林和庆大霉素的药代动力学
Perit Dial Int. 2001 Nov-Dec;21(6):587-94.
4
Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial.腹腔内头孢吡肟单药治疗与头孢唑啉联合头孢他啶经验性治疗 CAPD 相关性腹膜炎的组合治疗:一项多中心、开放标签、非劣效性、随机、对照试验。
Am J Kidney Dis. 2019 Nov;74(5):601-609. doi: 10.1053/j.ajkd.2019.05.011. Epub 2019 Jul 19.
5
Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.采用每日一次的头孢唑林方案对无万古霉素的腹膜透析腹膜炎进行初始治疗。
Am J Kidney Dis. 2001 Jan;37(1):49-55. doi: 10.1053/ajkd.2001.20581.
6
Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.头孢唑林和奈替米星与万古霉素和头孢他啶治疗持续性非卧床腹膜透析相关性腹膜炎的对比研究
Adv Perit Dial. 1997;13:218-20.
7
A comparison between oral ciprofloxacin and intra-peritoneal vancomycin and gentamicin in the treatment of CAPD peritonitis.口服环丙沙星与腹腔内注射万古霉素和庆大霉素治疗持续性非卧床腹膜透析相关性腹膜炎的比较。
J Antimicrob Chemother. 1990 Dec;26 Suppl F:73-6. doi: 10.1093/jac/26.suppl_f.73.
8
A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD).腹腔内注射环丙沙星与腹腔内注射万古霉素和庆大霉素治疗持续性非卧床腹膜透析(CAPD)相关腹膜炎的比较。
J Antimicrob Chemother. 1990 Dec;26 Suppl F:77-81. doi: 10.1093/jac/26.suppl_f.77.
9
A single-centre experience: peritoneal dialysis-related infections in patients on long-term dialysis.单中心经验:长期透析患者的腹膜透析相关感染
J Med Assoc Thai. 2011 Sep;94 Suppl 4:S30-6.
10
Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis.美罗培南联合妥布霉素继以美罗培南联合万古霉素治疗持续性非卧床腹膜透析患者腹膜炎的疗效及安全性
Adv Perit Dial. 2006;22:65-8.

引用本文的文献

1
Comparison of exit site infection and peritonitis incidences between povidone-iodine and normal saline use for chronic exit site care in peritoneal dialysis patients.比较聚维酮碘和生理盐水用于腹膜透析患者慢性出口部位护理时出口部位感染和腹膜炎的发生率。
Kidney Res Clin Pract. 2014 Sep;33(3):144-9. doi: 10.1016/j.krcp.2014.05.030. Epub 2014 Jul 23.
2
Pharmacokinetics of intraperitoneal gentamicin in peritoneal dialysis patients with peritonitis (GIPD study).腹腔内注射庆大霉素在腹膜炎患者腹膜透析中的药代动力学(GIPD 研究)。
Clin J Am Soc Nephrol. 2012 Aug;7(8):1249-56. doi: 10.2215/CJN.12211211. Epub 2012 Jun 14.
3
Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD) study.
优化腹膜炎患者腹腔内庆大霉素剂量(GIPD)研究。
BMC Nephrol. 2009 Dec 16;10:42. doi: 10.1186/1471-2369-10-42.
4
Ciprofloxacin treatment of bacterial peritonitis associated with chronic ambulatory peritoneal dialysis caused by Neisseria cinerea.环丙沙星治疗由灰色奈瑟菌引起的与持续性非卧床腹膜透析相关的细菌性腹膜炎。
J Clin Microbiol. 2006 Aug;44(8):3040-1. doi: 10.1128/JCM.00917-06.